APOA1 and chronic myelogenous leukemia, BCR-ABL1 positive: Likewise, a substantial curative effect of apoA-I:CIGB-258 at 1:0.1, 1:0.5, and 1:1 (molar ratio) was observed against CML-impaired granulation tissue formation.